Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CoMparison of TriflusAl and Clopidogrel Effect in Secondary Prevention of STroke Based on the CytochRome P450 2C19 GenOtyping (MAESTRO)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Gangnam Severance Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Myung In Pharmaceutical Company, Ltd.
Yonsei University
Information provided by (Responsible Party):
KyungYul Lee, Gangnam Severance Hospital
ClinicalTrials.gov Identifier:
NCT01174693
First received: August 3, 2010
Last updated: January 24, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)